Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 14.91
PID's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 14.91 )
Ranked among companies with meaningful P/E(ttm) only.
PID' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 14.91
Current: 14.91
0
14.91
PE(NRI) 14.91
PID's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 14.91 )
Ranked among companies with meaningful PE(NRI) only.
PID' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 14.91
Current: 14.91
0
14.91
P/B 1.25
PID's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 1.25 )
Ranked among companies with meaningful P/B only.
PID' s P/B Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 1.25
Current: 1.25
0
1.25

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.80
PID's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 3.80 )
Ranked among companies with meaningful Dividend Yield only.
PID' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 3.83
Current: 3.8
0
3.83
Yield on cost (5-Year) 3.80
PID's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 3.80 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PID' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 3.83
Current: 3.8
0
3.83

More Statistics

Short Percentage of Float0.00%
52-Week Range $11.44 - 18.41
Shares Outstanding (Mil)81,500,000.00
» More Articles for PID

Headlines

Articles On GuruFocus.com
New Home Sales Help Market Gain May 24 2016 
Baxter International Officer Invests in Stake May 24 2016 
Dutch Online Broker Binckbank Faces Substantial Headwinds May 24 2016 
Bernard Horn's 5 New Buys All Undervalued by Lynch Earnings Line May 24 2016 
Brandes Funds Comments on Publicis May 24 2016 
Brandes Funds Comments on Credit Suisse May 24 2016 
Brandes Funds Comments on Barclays May 24 2016 
Brandes International Equity Fund Q1 Commentary May 24 2016 
Brandes Funds Comments on Embraer May 24 2016 
Spirit Airlines' Selloff Is Unjustified May 24 2016 

More From Other Websites
Sanofi’s Diabetes and Cardiovascular Franchise Performance May 24 2016
New International Dividend Growth ETF by iShares in Focus May 24 2016
Why PotashCorp’s Gross Margins Fell in 1Q16 May 20 2016
A Peek at Sanofi’s Valuation Cheat Sheet May 19 2016
Novo’s Geographical Sales Split in 1Q16 May 06 2016
Why Did Agrium Perform Better Than Expected in 1Q16? May 06 2016
Low U.S. Interest Rates Boost International Dividend ETFs May 05 2016
How Did GlaxoSmithKline’s Global Pharmaceuticals Business Perform? May 05 2016
4 Best Dividend-Paying European Equity ETFs (FDD, IDVY) May 05 2016
How Has Novo’s Share Price Performed since Its Last Earnings? May 02 2016
PotashCorp Missed 1Q16 Estimates: What’s Next? May 02 2016
What Analysts Expect for CF Industries’ Gross Margins May 01 2016
Will Agrium Report a Dip in Sales in 1Q16? Apr 27 2016
Novartis’s Pharmaceutical Revenue Reported Growth in 1Q16 Apr 27 2016
PID: An ETF Performance Case Study Apr 20 2016
Oil Prices Are Tethered to Loads Of Overseas Stock ETFs, Too Apr 19 2016
Victoza to Fuel Growth for Novo Nordisk Apr 15 2016
Inside WisdomTree's New Dividend Growth ETF Apr 15 2016
Analyzing Novo’s Haemophilia and Growth Hormone Portfolio Apr 13 2016
How Is Novo Nordisk Doing in the Diabetes Space? Apr 12 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK